Introduction Older patients are more likely to acquire and die from acute respiratory distress syndrome (ARDS) and muscle weakness may be more clinically significant in older persons. Recent data implicate muscle ring finger protein 1 (MuRF1) in lung injury-induced skeletal muscle atrophy in young mice and identify an alternative role for MuRF1 in cardiac metabolism regulation through inhibition of fatty acid oxidation. Objectives To develop a model of lung injury-induced muscle wasting in old mice and to evaluate the skeletal muscle metabolomic profile of adult and old acute lung injury (ALI) mice. Methods Young (2 month), adult (6 month) and old (20 month) male C57Bl6 J mice underwent Sham (intratracheal H 2 O) or ALI [intratracheal E. coli lipopolysaccharide (i.t. LPS)] conditions and muscle functional testing.
Introduction
Acute respiratory distress syndrome (ARDS), a syndrome of acute lung inflammation caused by both direct and indirect acute lung insults, affects at least 200,000 persons per year in the United States alone (Force et al. 2012; Rubenfeld et al. 2005) . While ARDS mortality has decreased over the past decades (Matthay et al. 2012 ), a cadre of critical illness survivors has been left in the wake, many of whom are faced with severe functional limitation. One of the serious limitations that intensive care unit survivors face is skeletal muscle weakness, which may persist for years after the resolution of ARDS in many patients (Bienvenu et al. 2012; Herridge et al. 2011) . Studies have linked skeletal muscle weakness with mortality. One prospective multicenter cohort study investigated adults requiring at least 5 days of mechanical ventilation without evidence of pre-existing neuromuscular disease. They demonstrated that handgrip strength performed well as a diagnostic for the identification of ICU acquired paresis (ICUAP), with handgrip strength independently associated with hospital mortality (OR 4.5, p = 0.007) (Ali et al. 2008) . In a randomized controlled trial, prospectively collected data has demonstrated the impact of weakness on outcomes and costs in the adult ICU (Hermans et al. 2014) . Of 415 assessable long-stay ICU patients, 122 were identified as weak, defined by an MRC sum score \48, and matched by propensity scoring to 122 non-weak patients (Hermans et al. 2014) . Weak long-stay ICU patients were significantly less likely to wean from mechanical ventilation, leave the ICU, or be discharged from the hospital (Hermans et al. 2014) . The in-hospital costs per patients were ?30.5 % more than the matched not-weak patients and their 1 year mortality was 30.6 % (vs. 17.2 % in the not-weak group, p = 0.007) (Hermans et al. 2014) . While these studies demonstrate that ICU-acquired neuromuscular dysfunction independently increases mortality, it also prolongs duration of mechanical ventilation and contributes to long-term functional impairment (Ali et al. 2008; Hermans et al. 2014) , the mechanisms underlying the development ICU acquired neuromuscular dysfunction are incompletely understood and no pharmacologic therapies currently exist.
One well-defined risk factor for both acquisition of and mortality from ARDS is increased age (Amato et al. 2015; Rubenfeld et al. 2005) . Older ARDS patients also have profound functional impairment following severe critical illness, suggesting that ICU acquired neuromuscular dysfunction may be more severe in older patients (Ehlenbach et al. 2015; Ely et al. 2002; Ferrante et al. 2015) . The etiologies for these potential age-associated disparities in ICU acquired neuromuscular dysfunction in ARDS are unknown, but may relate to the underlying loss of muscle mass and function (sarcopenia) associated with aging (Cruz-Jentoft et al. 2010) . Therefore, it is important to understand the fundamental differences in ARDS-induced neuromuscular dysfunction across the age-span, as therapeutic strategies may differ in young and old patients.
Using a previously established model (Files et al. 2012 ), the present study investigated ALI-induced skeletal muscle wasting in adult (6-month) and old (20-month) lung-injured mice to evaluate potential age-dependent phenotypes. We then examined metabolic differences in the muscles of adult and old mice following lung injury, using both nontargeted and targeted metabolomics approaches. We identified distinct alterations in lipid and amino acid metabolism in the muscles of old ALI mice, paralleling their impaired functional recovery when compared to adult ALI mice.
Materials and methods

Animals and acute lung injury model
All procedures were approved by the Institutional Animal Care and Use Committee of Wake Forest School of Medicine. 2-month (young), 6-month (adult) and 20-month (old) male wild type C57BL/6 mice (The National Institute of Health Aging Mouse Colony) were anesthetized with an intraperitoneal (i.p.) injection of 150 mg/kg ketamine and 13.5 mg/kg acetylpromazine and the trachea exposed. Escherichia coli lipopolysaccharide (LPS) (O55:B5 L2880, lot 111M4035V, Sigma-Aldrich, St. Louis, MO) (ALI mice) at specified, weight-based dosages or an equivalent volume of sterile water (Sham mice) was instilled intratracheally using a 20-gauge catheter as previously described (Files et al. 2012) . Mice were observed for up to 10 days and harvested at specified time points. Daily food intake per mouse was obtained by weighing the daily food mass per cage divided by the number of mice in the cage in adult and old mice at baseline and following ALI conditions.
In vivo force measurements
Force measurements were made with an in vivo force transducer (Aurora Scientific, Aurora, Ontario, Canada) that measures force generation in vivo longitudinally over time in a single animal. Briefly, this apparatus measures force production by plantarflexion of the ankle mounted to a foot-plate to which the mouse hind foot is attached. Animals were anesthetized with 2 % inhaled isoflurane at a constant flow rate of 2 L/min. After removal of the animal's fur, the tibial nerve was located and an electrode was placed over the nerve. Resting tension, muscle length and stimulation current were iteratively adjusted for each muscle to obtain optimal twitch force. The nerve was then stimulated with 250 ms trains of pulses at increasing frequencies every 2 min and the maximum tetanic force was recorded for the force-frequency curves. The maximal force generated for each contraction was plotted as a percentage of the initial maximal force over the duration of the fatigue protocol. For the studies described, baseline force measurements were obtained on uninjured adult and old mice. Following the lung injury protocol at 0.75 or 1 lg/g LPS (low dose LPS), measurements were obtained again on days 3 and 10. The data is displayed as the percent change from baseline force at days 3 or 10 from the maximal tetanic forces generated at 125 Hz at each of these time points and is combined from two independent experiments.
Muscle extraction and morphometry
Following euthanasia, gastrocnemius (GAS), extensor digitorum longus (EDL), soleus (SOL) and tibialis anterior (TA) muscles were removed, blotted with tissue paper and immediately weighed. Muscles were snap frozen in liquid nitrogen as previously described (Files et al. 2015a) . Soleus muscles were prepared as previously described for muscle morphometry. For fiber typing data, type I or type II myofibers of the soleus muscle were identified using the ATPase method at pH 9.4 as previously described (Files et al. 2012) . Soleus muscle lipid content was identified on serial sections, using the Oil Red O (Poly Scientific R&D) staining method. Lipid droplet size measurements were obtained in at least 20 myofibers per muscle section and quantified using Image J Ò software (NIH, Bethesda MD) as previously described (Choi et al. 2016 ).
Western blotting
Western blotting was performed as previously described using the following antibodies: Trim63 (MuRF1) (AF5366 R&D Systems, Minneapolis, MN, USA), GAPDH (AM4300 Ambion, Austin, TX, USA) (Files et al. 2015a ).
Non-targeted metabolomics determination by GC-MS instrumentation
Gastrocnemius muscle tissue was flash frozen in liquid nitrogen, weighed (25-50 mg wet weight), then placed in buffer (50 % acetyl-nitrile, 50 % water, 0.3 % formic acid) at a standard concentration of 25 mg/475 ll buffer then fully homogenized on ice for 10-25 s and placed on dry ice/stored at -80°C. Samples were then analyzed by GC/ MS, as previously described (Banerjee et al. 2015) . The raw, transformed, and sorted data used for each of the three comparisons in the metabolomics analyses can be found in supplemental Table 2 contains raw and imputed data sets including both targeted and non-targeted data.
Targeted metabolomics of acyl-carnitine and amino acid quantification by GC-MS instrumentation
Amino acids and acyl-carnitines were analyzed using stable isotope dilution techniques. Amino acids and acylcarnitine measurements were made by flow injection tandem mass spectrometry using sample preparation methods described previously Jensen et al. 2006; Wu et al. 2004) . The data were acquired using a Waters Acquity TM UPLC system equipped with a TQ (triple quadrupole) detector and a data system controlled by MassLynx 4.1 operating system (Waters, Milford, MA). Metabolite concentrations were analyzed using Metaboanalyst v3.0 (Xia et al. 2009 (Xia et al. , 2011 (Xia et al. , 2015 run in the statistical package R (v2.14.0). Initial unsupervised evaluation using principal component analysis (PCA) identified the presence of acute lung injury as the primary source of variance. Data were next analyzed using PLSDA and VIP analyses in a similar manner to what was previously described. Metabolites that best differentiated the groups were individually tested using Metaboanalyst v3.0 t test feature. Of note, metabolites were normalized by reference sample created from Sham group average.
Metabolomic statistical analyses
Metaboanalyst (v3.0) run on the statistical package R (v2.14.0) used metabolite peaks areas (as representative of concentration) (Xia et al. 2009 (Xia et al. , 2015 . These data were first normalized to a pooled average sample created from their control-Sham group, and scaled using Pareto scaling feature, and then analyzed to calculate Fold change using Metaboanalyst fold change feature. Unsupervised principal component analysis (PCA) was performed next, which identified the presence of the acute lung injury in the mice as the principal source of variance. The metabolites that best differentiated the groups were then individually tested using univariate analysis of individual component by t-test (Metaboanalyst v3.0), and then both the t-test and VIP significant metabolites were matched to metabolomics pathways using the Pathway Analysis and enrichment analysis features in Metaboanalyst v3.0. To detect systemic metabolic signature of ALI in the context of age, a One-Way Analysis of Variance (ANOVA) and Fisher LSD post hoc test across the two ages (adult, old) and experimental groups (sham, ALI)(adult sham, adult ALI, old sham, old ALI) using Metaboanalyst v3.0 including p values. Similarly, the metabolic signatures from these gastrocnemius groups were compared to MuRF1 Tg? and MuRF1-/-hearts using a OneWay Analysis of Variance (ANOVA) and Fisher LSD post hoc test to compare adult Sham, adult ALI, old Sham, old ALI, wildtype MuRF1Tg? , MuRF1 Tg?, MuRF1?/?, MuRF1-/-. Only metabolites identified and detected in all groups were included in the One-Way ANOVA. If four or more values of each metabolite were missing in a given group, the entire metabolite was removed from the analysis. Only metabolites significantly altered in 2 or more organs were plotted. Data used in this study are available in supplemental Tables 1 and Table 2 . Heat maps were generated using the GENE-E software (http://www.broadinstitute.org/ cancer/software/GENE-E/index.html).
Other statistical analyses
All data is shown as mean ± SEM, unless otherwise indicated. Differences between two groups were compared with the Student's t test or the Mann-Whitney test for nonparametric data, while comparisons between [2 groups used a One-Way ANOVA. Post-hoc analysis was performed using a t-test with the Bonferroni adjustment method using Prism 7.0 (GraphPad Software, Inc., La Jolla, CA).
Results
Instillation of lipopolysaccharide (LPS) at a dose previously established to cause a survivable lung injury and muscle wasting in young mice caused a step-wise and agedependent increase in mortality. At 10 days following intratracheal (i.t) LPS, 87 % of young and 77 % of adult mice survived, but none of the old mice did (Fig. 1a) . Since this paradigm did not allow investigation of chronic skeletal muscle alterations post-acute illness, we adjusted the model to create a reproducible survival model of ALI in old mice. To do this, we incrementally reduced the LPS dose and observed the dose-related survival response. We found that reducing the dose to 0.75 or 1 lg/g LPS (low dose LPS) led to survival in *75 % of the old ALI mice and 100 % survival in adult ALI mice (Fig. 1b) . Low dose i.t. LPS caused profound body weight loss (Fig. 1c) in both adult and old ALI mice during the early phase (days 0 through 5), though maximal body weight loss peaked at day 3 in adult ALI mice (16 % below baseline) and body weight loss peaked at day 5 in old ALI mice (21 % below baseline). During the late phase (days 6 through 10), both adult and old ALI mice gained weight at a similar rate, but the old ALI mice body weight recovery started from a lower baseline. Mean daily baseline food intake was similar in young (3.7 g/day) and old (3.2 g/day) mice. Following low dose ALI, food intake dropped to *12 % of baseline daily food intake for the first 2 days in both groups, and then slowly increased through day 9 where they were similar to the baseline levels of daily food intake ( Fig. 1d) .
Despite body weight recovery in old ALI mice during the late phase, muscle function failed to recover. Maximal tetanic force generated from the hindlimb ankle plantar flexor muscle group in the adult and old mice at baseline, days 3 and 10, was reduced in old ALI mice at day 10 (compared to both old baseline and adult ALI mice at day 10). In contrast, there was no evidence of significant weakness from baseline levels in adult ALI mice at either timepoint (Fig. 1e) . Analysis of the tibialis anterior (TA) and extensor digitorum longus (EDL) wet weights demonstrated reduced muscle mass in both adult and old ALI mice at day 10, although the percent of muscle mass lost in old ALI mice (vs old Sham) was equivalent or less than that observed in the adult ALI mice (vs adult Sham) (Fig. 1f, g ). In contrast, muscle mass was preserved in the soleus in both adult and old ALI mice (Fig. 1h) , supporting a relative preservation of type I myofibers in the limb muscles under ALI conditions (Files et al. 2015a) .
Previous studies have implicated the muscle specific ubiquitin ligase (MuRF1) in skeletal muscle atrophy (Bodine et al. 2001) , and have demonstrated that MuRF1 Fig. 1 Lung injury in old mice results in increased mortality and prolonged muscle weakness. a Survival curves for young (2 month old), adult (6-month old) and old (20-month old) acute lung injury (ALI) mice following high dose (3 lg/g) LPS. N = 37/very young, N = 13/ adult, N = 3/old. b LPS dose titration in old ALI mice, at doses ranging from 0.75 to 1.5 lg/g. N = 11/adult (0.75 lg/g), N = 11/old (0.75 lg/ g), N = 8/old (1 lg/g), N = 6/old (1.25 lg/g), N = 6/old (1.5 lg/g). c Cumulative body weight changes in adult and old Sham and ALI (0.75 lg/g) mice following intratracheal (i.t.) H 2 O or i.t. LPS. N = 3 for Sham groups, N = 10 ALI groups. d Mean daily food intake in Adult and Old baseline and ALI mice. N = 6 per group. e The percent change in maximal tetanic force by ankle plantarflexion generated at 125 Hz stimulation at days 3 and 10 following 0.75 or 1 lg/g LPS was compared to baseline values in individual animals; #Old baseline vs Old Day 10 p = 0.007, @Adult ALI Day 10 vs Old ALI Day 10 p = 0.004, N = 10 Adult baseline, N = 13 Old baseline, N = 6 ALI Adult day 3, N = 6 ALI Old day 3, N = 10 ALI Adult day 10, N = 7 ALI Old day 10. Sham or ALI (0.75 lg/g) muscle wet weights of the f tibialis anterior (TA) g extensor digitorum longus (EDL) or h soleus (SOL) muscles at day 10. Gastrocnemius protein lysates from i Day 3 and j Day 10 ALI (0.75 lg/g) or Sham mice were probed for MuRF1 expression, normalized GAPDH and quantified by densitometry (N = 3 for Sham mice, N = 5-6 for ALI groups). k Staining for intramyocellular lipid (IMCL) accumulation (red arrows) in type I and type II myofibers of the soleus in Adult and Old ALI mice at day 10. N = 3/group, *p = 0.04 for group differences expression is necessary to cause ALI-induced muscle atrophy (Files et al. 2012; Langen et al. 2012) . We then investigated MuRF1 protein in all groups. Western blot analysis of MuRF1 in the gastrocnemius muscle, a mixed fiber type muscle, identified significant upregulation in both adult and old ALI mice (compared to Sham), which was higher in the old ALI mice compared to adult ALI mice at day 3 (Fig. 1i) . However, at day 10, when old ALI mice displayed profound muscle weakness, MuRF1 levels had returned to baseline (Fig. 1j) . This finding, along with the lack of reduced muscle mass at day 10, suggest that atrophy does not account for the loss of muscle function in old mice at day 10. Further histological evaluation of soleus muscle in ALI mice revealed increased intramyocellular lipid (IMCL) droplet size in old versus young ALI mice at day 10 in both type I and type II myofibers (Fig. 1k) , a finding associated with both impaired skeletal muscle function (Choi et al. 2016; Picard et al. 2012 ) and metabolism (Consitt et al. 2009 ) in previous studies.
To explore potential underlying muscle metabolic defects in adult and old ALI mice during the late phase, we performed non-targeted metabolomics analysis on gastrocnemius muscle samples of adult and old, Sham and ALI mice at day 10. We first compared the adult ALI to adult Sham groups (Fig. 2) , then similarly analyzed the old ALI muscle metabolomic profile (Fig. 3) . Analysis of the adult ALI gastrocnemius profile identified 111 metabolites, 66 of which were named (Fig. 2a) . A supervised partial least squares regression discriminant analysis (PLS-DA) identified distinct alterations in the metabolomics profile, with the first principal component accounting for 28.6 % of the differences observed between groups (Fig. 2b) . The associated Variable Importance in Projection (VIP) analysis identified 5 metabolites with VIP scores [2, including lactic acid, taurine, cholesterol, glucose-6-phosphate, and glucose and other aldohexoses (Fig. 2c) . A t-test analysis identified 9 metabolites to be significantly different, including hydroxyprolines, glutamine, beta-alanine, aminomalonic acid, and linoleic acid that were significantly decreased 20-30 % or significantly increased 30-236 % from controls ( Fig. 2d) (p \ 0.05). Parallel analysis of the old ALI muscle compared to old Sham identified 111 metabolites, 69 of which were named (Fig. 3a) . PLS-DA identified distinct alterations in the metabolomic profile, with the first principal component accounting for 35.6 % of the differences observed between groups (Fig. 3b) . The associated Variable Importance in Projection (VIP) analysis identified 3 metabolites with VIP scores [2, including lactic acid, phosphoric acid, and glucose/other aldohexoses (Fig. 3c) . A t-test analysis identified 18 metabolites, including elevations in 2-aminoadipic acid, hydroxyprolines, lysine, linoleic acid, glutamic acid, aspartic acid, and phenylalanine to be significantly decreased to 55-85 % or significantly increased 33-233 %) compared to old Sham muscle (Fig. 3d) (p \ 0.05) . In contrast to the adult ALI gastrocnemius, the old ALI gastrocnemius generally had more significantly different amino acids (5 in old ALI compared to 3 in the adult ALI), and fatty acids identified by t-test (5 in old ALI compared to 2 in the adult ALI).
We next sought to determine what underlying pathways were altered in the adult and old ALI muscle using the specific metabolites identified in Figs. 2d and 3d as t-test and VIP significant. Using pathway enrichment analysis, we identified metabolomics alterations in the adult ALI enriched primarily in inositol phosphate, pyrimidine, galactose and D-glutamine metabolism (Fig. 4a) , reflected in Ammonia Recycling pathway enrichment of 6? fold and the lowest p value (Fig. 4b) . Additional enrichment analyses against disease-associated metabolite sets identified mammary-tumor-bearing mice and 3-methylglutaonic aciduria (type II) (supplemental Fig. 1a ), Alzheimer's disease, and 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (supplemental Fig. 1b) with the lowest p values. Enrichment based on location identified the basal ganglia (supplemental Fig. 1c ) with the lowest p value. Pathway enrichment analysis in the old ALI muscle revealed alterations in lysine biosynthesis, amino acids biosynthesis and biosynthesis of unsaturated fatty acids (p \ 0.05) (Fig. 4c) . Further enrichment analysis of pathway-associated metabolite sets highlighted significant enrichment of alpha-linoleic acid and linolenic acid metabolism ([ninefold enrichment), glucose-alanine cycle (sevenfold enrichment), biotin metabolism (tenfold enrichment) and protein biosynthesis (sevenfold enrichment and lowest p value) (Fig. 4d) . Additional enrichment analyses against disease-associated processes identified alterations with the lowest p value associated with the 2-ketoglutarate dehydrongenase process (supplemental Fig. 2a ), Glut-1 deficiency (supplemental Fig. 2b ), 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency and metabolic enrichment in bladder and skeletal muscle (supplemental Fig. 2c) .
Interestingly, both adult and old ALI muscle was enriched for 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, an inborn error caused by a defect in the degradation of the branched chain amino acid isoleucine. Characterized by severe motor defects, disrupted mitochondria, and accumulation of intracellular lipids, 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency exhibits aspects of altered fatty acid metabolism (Chatfield et al. 2015) . Together, these findings helped focus our attention on the amino acid and fatty acid metabolic alterations in ALI muscle for further targeted analysis.
Next, we next performed a targeted quantitative analysis of 15 amino acids and 40 acyl-carnitines (grouped into analysis for adult (6-month) acute lung injury compared to Sham controls. a-e indicates top pathways identified, along with the specific significant metabolites found that placed it in this category. b Enrichment by metabolite sets determined from VIP and t-test significant metabolites identified in adult ALI mice compared to their adult Sham. c Pathway enrichment analysis for old ALI compared to old Sham a-e indicates top pathways identified, along with the specific significant metabolites found that placed it in this category. d Enrichment by metabolite sets determined from VIP and t-test significant metabolites identified in old ALI compared to old Sham. a-e indicates top pathways identified, along with the specific significant metabolites found that placed it in this category Lung injury-induced skeletal muscle wasting in aged mice is linked to alterations in long… Page 9 of 16 134 short, medium, and long chain acyl-carnitines) on adult ALI (Fig. 5a ) and old ALI muscle (Fig. 5d) . The Unsupervised PCA analysis of targeted metabolomics between adult ALI and adult Sham mice groups revealed alanine as the only metabolite with a VIP score [2 (Fig. 5b) . Three t-test significant metabolites were also identified: (1) histidine, (2) citrulline, and (3) ornithine (Fig. 5c) . Complementary studies of the old ALI muscle (Fig. 5d) revealed that alanine and glutamine had VIP scores [2 (Fig. 5e) . Similar to the adult ALI, the old ALI had t-test significant increases in citrulline and ornithine (Fig. 5f ), but uniquely old but not adult ALI mice had a nearly 50 % reduction in long chain acyl-carnitines (Fig. 5f ).
To delineate the underlying mechanisms occurring in both an age-dependent and ALI-dependent manner across all four groups studied, we next performed a One-Way ANOVA across both adult and old Sham and ALI groups (Fig. 6 ). Of the 64 metabolites identified in all four groups (Fig. 6a) , unique PCA patterns were seen between the four groups (Fig. 6b) . 22 metabolites were significantly different using ANOVA analysis (Fig. 6c) . Further inter-group analysis identified age-dependent differences, between old Sham and adult Sham muscle in metabolites including docosahexaenoic acid, 2-aminoadipic acid, pyruvic acid, lysine, and ononitol (see $, Fig. 6c ). In addition to these metabolites that were different between the adult Sham and old Sham muscle, we also evaluated metabolite alterations in both old groups (old Sham and old ALI) and identified urea and docosahexanoic acid (DHA) (supplemental Fig. 3a) . To determine metabolites that were significantly altered in ALI regardless of age, we identified altered metabolites found in both ALI groups (supplemental Fig. 3a) . DHA was significantly increased in an age-dependent fashion (supplemental Fig. 3b ), whereas linoleic acid was significantly increased in ALI conditions regardless of age (supplemental Fig. 3c ). In addition, lactate, serine, and alanine were differentially regulated in ALI conditions regardless of age (supplemental Fig. 3a) .
In order to further examine potential changes in of acylcarnitines observed in old ALI mice, we grouped measured acyl-carnitines by chain length and plotted the fold change in old ALI versus old Sham muscle against carbon chain length. This analysis further illustrates that the long chain species were most affected (supplemental Fig. 4) . These alterations were reminiscent of the reduced long chain acyl-carnitines seen with increased MuRF1 expression in a prior metabolomics cardiac muscle analysis (Rodriguez et al. 2015) . To determine if there were any similarities in the present study (particularly old ALI) with altered MuRF1 signatures in the heart, we performed an ANOVA across the four groups in the present study with the four groups in our previous study (MuRF1 Tg? and MuRF1-/-and their strain matched controls). Significant alterations in both the grouped long chain (C14-C22) and short chain (C2-C5) acyl-carnitines were seen, along with specific species (supplemental Fig. 5a ). Interestingly, the total long chain acyl-carnitines (C14-C22) were significantly depressed similarly to the MuRF1 Tg? hearts, with the MuRF1-/-hearts having significantly increased levels of total long chain acyl carnitines (supplemental Fig. 5b) . We then plotted all of the acyl-carnitines C2-C20 levels for each of the four groups compared to their wildtype controls, which run along the dotted line at 1.0 (supplemental Fig. 5c ). We found that the old ALI and MuRF1 Tg? hearts with increased cardiomyocyte MuRF1 expression follow a parallel acyl-carnitine reduction, affecting the longer acyl-carnitines most (supplemental Fig. 5c , red and green lines). Similarly, adult ALI muscle has reduced levels of longer chain acyl-carnitines (blue line), but are not as severely affected as the old ALI mice. In contrast, the loss of MuRF1 (MuRF1-/-hearts) have increased levels of short and medium chain acyl-carnitines, with the largest increases (compared to wildtype) being in the long chain acyl-carnitine species (gray line) (supplemental Fig. 5c ). The significantly altered acyl-carnitine species (vs. adult Sham) determined by ANOVA in any group are indicated in supplemental Fig. 5d , having enrichment for cyanoaminoacid, linoleic, and methane metabolism (supplemental Fig. 6 ).
Discussion
The relationship between age and increased incidence of and mortality from acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) has been established in both humans and animal models (Manzano et al. 2005; Prows et al. 2015; Rubenfeld et al. 2005) . Increasing evidence suggests that neuromuscular weakness developing from critical illness is independently associated with morbidity and mortality, and is therefore an attractive therapeutic target (Ali et al. 2008; Hermans et al. 2014) . While it has been suggested that older patients exhibit increased severity of ICU acquired neuromuscular weakness, this has been understudied and the mechanisms are unknown (Ehlenbach et al. 2015; Ely et al. 2002; Ferrante et al. 2015 Ferrante et al. , 2016 . In this manuscript, we present a model of an age-associated increase in mortality from lung injury, coupled with prolonged neuromuscular dysfunction. Muscle wasting in old ALI mice is associated with increased MuRF1 expression during the early phase relative to adult mice; however, no difference is observed in MuRF1 expression in the late phase. Additionally, similar or decreased relative muscle loss is observed in the old mice in the late phase, suggesting that prolonged muscle weakness is due to processes other than muscle atrophy. The dissociation of muscle mass and muscle strength found in the present study has been previously described in various conditions, including sarcopenia (Baehr et al. 2016; Goodpaster et al. 2006; Metter et al. 1999 ). The potential physiologic explanations for this dissociation are many, including neuropathies, neuromuscular junction injury, and excitation-contraction uncoupling among others. In light of our findings of profound metabolic alterations during the late phase of lung injury, we believe changes in muscle metabolism represent a potential mechanism underlying the dissociation between muscle mass and function. Previous work has demonstrated that changes in energy substrate and utilization (metabolism) can affect muscle performance (Li et al. 2015; Pugh et al. 2013) . While the mechanistic link between the metabolic changes seen in old mouse muscle and the reduction in muscle contractile force are not fully elucidated in this study, we find increased size of intramyocellular lipid droplets in old ALI muscle at day 10. Other studies have found an association between intramyocellular lipid accumulation and impaired muscle contractility in mice and humans (Choi et al. 2016; Duval et al. 2007; Picard et al. 2012; Pugh et al. 2013) , though the mechanisms underlying this association remain unclear.
Age-related changes have been identified in rat muscle related to glycolytic metabolism (32 vs. 15 month rats) (Garvey et al. 2014) . Specifically, an accumulation of glycolytic, glycogenolytic, and pentose phosphate pathway intermediates in addition to increases in monounsaturated fatty acids (e.g. oleate and palmitoleate) were found in aged rat gastrocnemius (Garvey et al. 2014) . The age-associated increases in long chain fatty acids (oleate and palmitoleate) found in this study, are similar to our findings of elevated long chain poly-unsaturated docosahexaenoic acid (DHA) in old versus adult Sham mice. Low plasma DHA levels in cancer patients have been associated with myosteatosis, and supplementation with DHA and other x-3 fatty acids may improve muscle function in this population (as recently reviewed (Ewaschuk et al. 2014) ). The etiology and causality of elevated DHA in the muscle of old mice from our study is unclear. This finding may reflect an inability of old muscle to utilize DHA, or alternately, DHA may be a compensatory adaptive response in aged muscle. As dietary supplementation with DHA holds potential for therapy for muscle wasting in cancer and other conditions, further study is needed to explain the etiology of DHA and other long chain fatty acids in aged muscle (Ewaschuk et al. 2014; Kamolrat and Gray 2013; Smith et al. 1999) .
The poly-unsaturated x-6 fatty acid, linoleic acid was significantly increased after ALI in both adult and old mice. While a mechanistic link between ALI and increased linoleic acid in muscle is not clear, several studies have linked alterations in plasma linoleic acid with acute lung injuries, including ARDS, pneumonia, and septicemia though underlying mechanisms appear unclear (Kumar et al. 2000; Prabha et al. 1991) . While these alterations have been implicated in ARDS pathogenesis, their roles still remain unclear. The potential role of enhanced inflammation and utilization of polyunsaturated fatty acids via lipid peroxidation (Quinlan et al. 1996) deserves further study.
Linoleic acid is a substrate required for inflammation, but has also been proposed as an anti-inflammatory therapy for skeletal muscle disorders (Tarnopolsky and Safdar 2008; Tian et al. 2011) . Conjugated linoleic acid has been used therapeutically and for its anti-inflammatory properties (Larsen and Crowe 2009; Pariza et al. 1999; Zulet et al. 2005) , however, its use to protect against muscle weakness has not specifically been investigated. While linoleic acid unexpectedly was not protective in a tumor-mediated model of skeletal muscle atrophy using the C26 cell line in vivo, it enhanced markers of inflammation (Tian et al. 2011) . In resistance training, the addition of conjugated linoleic acid has been shown to reduce body fat after 6-months of resistance training in older adults (Tarnopolsky and Safdar 2008) . The observed increase in muscle linoleic acid in our study may reflect its role as a substrate for inflammation used to mobilize energy stores from fat systemically. Further work is needed to evaluate the etiology of this pathway in skeletal muscle functional recovery in the ALI model. Metabolites previously related to ALI and age are boxed in red; metabolites related to age only are shown in green. Significance defined as p \ 0.05. 22 metabolites were significantly different using ANOVA analysis (Fig. 6c) . Further inter-group analysis identified age-dependent differences, between old Sham and adult Sham muscle in metabolites including docosahexaenoic acid, 2-aminoadipic acid, pyruvic acid, lysine, and ononitol (see $, Fig. 6c ). In addition to these metabolites that were different between the adult Sham and old Sham muscle, we also evaluated metabolite alterations in both old groups (old Sham and old ALI) and identified urea and docosahexanoic acid (DHA) (supplemental Fig. 3a ). To identify metabolites that were significantly altered in ALI regardless of age, we identified altered metabolites found in both ALI groups (supplemental Fig. 3a) . DHA was significantly increased in an age-dependent fashion (supplemental Fig. 3b ), whereas linoleic acid was significantly increased in ALI conditions regardless of age (supplemental Fig. 3c ). In addition, lactate, serine, and alanine were differentially regulated in ALI conditions regardless of age (supplemental Fig. 3a) The significant decrease in long chain acyl-carnitines that were unique to the old ALI muscle suggests impaired uptake and/or utilization of long chain fatty acids for b oxidation. We also found that old ALI muscle closely parallels a similar acyl-carnitine profile from the MuRF1 Tg? hearts and contrasts the observed profile in MuRF1-/-hearts. Since MuRF1 is elevated to a greater degree in old compared to adult ALI mice during the early phase, these alterations in acyl-carnitine levels may reflect increased MuRF1 activity in old ALI mice. The mechanism in the heart for this inhibition of fatty acid oxidation has been found to be due to MuRF1 mono-ubiquitination of PPARa, which targets PPARa for nuclear export thereby decreasing PPARa activity (Rodriguez et al. 2015) . Further studies are needed to evaluate the potential link between elevated MuRF1 and the observed metabolomic pattern of impaired fatty acid oxidation in the muscles of old ALI mice.
Subsets of patients with a variety of diseases affecting seemingly disparate organ systems experience muscle wasting syndromes, which are associated with poor outcomes (Morley et al. 2006) . However, the kinetic relationship between muscle wasting and the presence of the underlying disease in various muscle wasting syndromes appear to differ. For instance, in diseases such as cancer, heart failure and chronic obstructive pulmonary disease (COPD), muscle wasting occurs in parallel with the ongoing disease state. In contrast, in critical illnesses, such as ARDS or sepsis, a massive inflammatory response likely drives the initial muscle injury, yet weakness persists in many patients despite resolution of the initial disease process (Files et al. 2015b) . While the muscle proteolytic response in these diseases many have common underlying mechanisms, such as MuRF1 involvement (Bodine and Baehr 2014) , the differing kinetics suggest that the underlying mechanisms and metabolic responses might differ.
Recent studies have demonstrated that the metabolomics profiles of muscle atrophy are different depending upon the underlying causes of muscle loss. In healthy mice challenged with cancer (no cachexia/muscle loss), cancer cachexia (early and late time points), calorie restrictioninduced muscle loss, and a control group, NMR analysis of serum identified distinct profiles of the cancer cachexia compared to other groups (hyperlipidemia, hyperglycemia, reduced branched-chain amino acids) (Der-Torossian et al. 2013) . While these findings confirmed previous studies that identified increases in cancer-cachexia plasma (O'Connell et al. 2008) , they offered a proof that cure (by surgical resection) paralleled predictable resolution of these changes (Der-Torossian et al. 2013 ). In another model of cancer cachexia, incubation of human muscle cells with cachectic conditioned media led to upregulation of fatty acid metabolism pathways and in increase in acyl-carnitines. This process was associated with muscle atrophy, and inhibition of FA metabolism attenuated atrophy (Fukawa et al. 2016 ). These studies demonstrate similarities to our present work, but differences may be due to the methodologies employed (NMR), the differences in the metabolite kinetics between disease processes, age differences, and the lack of ongoing atrophy in the clinically relevant present model. Future studies should evaluate the plasma and muscle metabolomics response during the early phase of our model and investigate the mechanistic link to MuRF1 to determine its potential as a therapeutic target. These studies might shed light on common metabolic mechanisms that may underlie muscle wasting in various disease states.
Conclusions
• Acute lung injury (ALI) in old mice reproduces the observed increase in mortality and muscle weakness in older humans with ALI/ARDS.
• The early phase of muscle wasting in old ALI mice is marked by increased MuRF1, while the late phase is marked by prolonged neuromuscular weakness and metabolomics alterations despite cessation of atrophy.
• Age-dependent muscle metabolite alterations included altered DHA and urea concentrations. ALI-dependent muscle metabolite alterations included linoleic acid, lactate, serine, and alanine, with old ALI muscle demonstrating significantly higher levels of linoleic acid than adult ALI.
• Long chain (C14-C22) acyl-carnitine species were depressed in old ALI muscle suggestive of impaired uptake or utilization of long chain fatty acids for b oxidation.
• The acyl-carnitine profile in old ALI muscle in the late phase coupled with early MuRF1 upregulation during the early phase parallels the MuRF1 Tg? cardiac muscle profile, suggesting that MuRF1 may contribute to the metabolic changes in old ALI muscle.
